Last month the U.S. Food and Drug Administration (FDA) approved rivaroxaban (Xarelto), a factor Xa inhibitor, for the treatment and prevention of acute deep vein thrombosis (DVT) and pulmonary embolism...making it the first oral anti-clotting drug approved for the treatment of blood clots since warfarin (Coumadin) almost 60 years ago.
New Drug Application
Hello bloggers, Recently when I was going on through an article found that in certain people, follicle stimulating gonadotrophin and interstitial cell-stimulating hormone of the anterior pituitary gland are supplemented. Let us see how they are being substituted...
Oral strip technology; an overview
Hello and welcome to my audio blog,
In this oral blog I present an overview on oral strip technology
It includes following information
1)An introduction to novel drug delivery giving the importance of oral films…